Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1994-09-27
1997-03-18
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241861, 4242791, 435 693, 935 65, A61K 39245
Patent
active
056120419
ABSTRACT:
Vaccines against Herpes Simplex virus containing recombinant polypeptides which are cross-reactive with glycoprotein D of the virus, methods for their production using recombinant DNA techniques in yeast, and methods for the use of the vaccine are provided. E. coli strains HB101 containing plasmids pYHS 109 and pYHS118 were deposited at the American Type Culture Collection on Jul. 11, 1984, and granted accession nos. 39762 and 39763, respectively.
REFERENCES:
patent: 4317811 (1982-03-01), Bertland et al.
patent: 4374127 (1983-02-01), Larson et al.
patent: 4618578 (1986-10-01), Burke et al.
patent: 4642333 (1987-02-01), Person
patent: 4661349 (1987-04-01), Kino et al.
patent: 4724146 (1988-02-01), Kino et al.
patent: 4762708 (1988-08-01), Cohen et al.
patent: 4818694 (1989-04-01), Watson et al.
patent: 4855224 (1989-09-01), Berman et al.
patent: 4870008 (1989-09-01), Brake
patent: 4891315 (1989-08-01), Watson et al.
Hilfenhaus et al., Devel. Biol. Standard. (1982) 52:321-331.
Watson et al., Science (1982) 218:381-384.
Weis et al., Nature (1983) 302:72-74.
Berman et al., Science (1983) 222:524-527.
Lasky et al., Biotechnology (Jun. 1984) pp. 527-532.
Cohen et al., J. Virol., (1984) 49:102-108.
Dundarov et al., Devel. Biol. Standard. (1982) 52:351-357.
Skinner et al., Devel. Biol. Standard. (1982) 52:333-344.
Eberle et al., J. Infect. Dis. (1983) 148(3):436-444.
Marsden et al., J. Virol. (1978) 28(2):624-642.
Ruyechan et al., J. Virol. (1979) 29(2):677-697.
Skare et al., Virology (1977) 76:581-595.
Roizman et al., Ann. Rev. Genetics (1979) 13:25-57.
Berman et al., Science (1985) 227:1490-1492.
Cappel et al., J. Medical. Virol. (1985) 16:137-145.
Pellet et al., J. Virol. (1985) 53(1):243-253.
Bzik et al., Virology (1984) 133:301-314.
Chan Immunology (1983) 49:343-352.
Roizman et al., Develop. Biol. Stand. (1982) 52:287-304.
Cohen, J. 1994. Science, vol. 264, pp. 503-506.
Straus, S. E. et al. 1985. Annals of Internal Medicine, vol. 103, pp. 404-419.
Sabin, A. B. 1981. JAMA, vol. 246, pp. 236-241.
Watson et al. Science vol. 218 1982 p. 381.
Berman et al. Science vol. 227 Mar. 1985, p. 1490.
Brake et al. Proc. Nat. Acad. Sci vol. 81 pp. 4642-4646 Aug. 1984.
Burke Rae L.
Urdea Mickey S.
Valenzuela Pablo D. T.
Blackburn Robert P.
Chiron Corporation
McClung Barbara G.
Mosher Mary E.
Robins Roberta L.
LandOfFree
Recombinant herpes simplex gD vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant herpes simplex gD vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant herpes simplex gD vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1704189